Published • loading... • Updated
NeoSep1, a landmark clinical trial to transform treatment options for newborns with sepsis, expands to Asia
Summary by Penta
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
NeoSep1, a landmark clinical trial to transform treatment options for newborns with sepsis, expands to Asia
Geneva, 24 June 2026 - An innovative international clinical trial to evaluate life-saving antibiotic combinations for newborns with sepsis has expanded to India, one of several Asian countries participating in the study. Sponsored by the GARDP Foundation (known as GARDP), the NeoSep1 clinical trial in India began with the first baby recruited at Jawaharlal Postgraduate
Landmark clinical trial to transform treatment options for newborns with sepsis expands to Asia
Geneva, 24 June 2026 — An innovative international clinical trial to evaluate life-saving antibiotic combinations for newborns with sepsis has expanded to India, one of ... Landmark clinical trial to transform treatment options for newborns with sepsis expands to Asia Source
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
